SecSonar.com

Aurora Cannabis Inc. (ACB)

Aurora Cannabis Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Aurora Cannabis Inc. (ACB) is a Drug Manufacturers - Specialty & Generic company based in CA with a market capitalization of $203.3M. Revenue grew 27.0% year-over-year and free cash flow was negative at -$2M. This page tracks ACB's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CA · 1.07K employees · IPO Jul 15, 2014

Valuation

Valuation & price

$3.45 · as of May 26, 2026 · -44.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$6.10$4.46$2.83Jul 25Dec 25Jul 26Jul 7, 25$4.43Jul 9, 25$4.57Jul 11, 25$4.49Jul 15, 25$4.49Jul 17, 25$4.55Jul 21, 25$4.70Jul 23, 25$4.88Jul 25, 25$4.84Jul 29, 25$4.44Jul 31, 25$4.43Aug 4, 25$4.62Aug 6, 25$4.24Aug 11, 25$5.21Aug 13, 25$5.53Aug 15, 25$5.08Aug 19, 25$4.76Aug 21, 25$4.78Aug 25, 25$5.23Aug 27, 25$5.33Aug 29, 25$5.42Sep 3, 25$4.91Sep 5, 25$4.91Sep 9, 25$5.05Sep 11, 25$4.93Sep 16, 25$5.00Sep 18, 25$5.18Sep 22, 25$5.03Sep 24, 25$5.18Sep 26, 25$4.86Sep 30, 25$5.96Oct 2, 25$5.68Oct 6, 25$5.81Oct 8, 25$6.10Oct 10, 25$5.30Oct 14, 25$5.49Oct 16, 25$5.29Oct 21, 25$5.14Oct 23, 25$5.11Oct 27, 25$5.09Oct 29, 25$4.95Oct 31, 25$4.95Nov 4, 25$4.54Nov 6, 25$4.36Nov 10, 25$4.67Nov 12, 25$4.53Nov 14, 25$4.31Nov 18, 25$4.43Nov 20, 25$4.08Nov 25, 25$4.48Nov 28, 25$4.60Dec 2, 25$4.48Dec 4, 25$4.57Dec 8, 25$4.47Dec 10, 25$4.53Dec 12, 25$5.40Dec 16, 25$5.53Dec 18, 25$5.38Dec 22, 25$4.69Dec 24, 25$4.57Dec 29, 25$4.31Jan 2, 26$4.34Jan 6, 26$4.24Jan 8, 26$4.27Jan 12, 26$4.26Jan 14, 26$4.26Jan 16, 26$4.23Jan 21, 26$4.24Jan 23, 26$4.43Jan 27, 26$4.42Jan 29, 26$4.18Feb 2, 26$3.92Feb 4, 26$3.75Feb 9, 26$3.59Feb 11, 26$3.44Feb 13, 26$3.55Feb 18, 26$3.55Feb 20, 26$3.77Feb 24, 26$3.79Feb 26, 26$3.89Mar 2, 26$3.71Mar 4, 26$3.65Mar 6, 26$3.51Mar 10, 26$3.54Mar 12, 26$3.51Mar 17, 26$3.53Mar 19, 26$3.38Mar 23, 26$3.31Mar 25, 26$3.42Mar 27, 26$3.20Mar 31, 26$3.27Apr 2, 26$3.44Apr 7, 26$3.37Apr 9, 26$3.48Apr 13, 26$3.48Apr 15, 26$3.68Apr 17, 26$3.66Apr 22, 26$3.80Apr 24, 26$3.39Apr 28, 26$3.42Apr 30, 26$3.44May 4, 26$3.42May 6, 26$3.54May 8, 26$3.41May 12, 26$3.36May 14, 26$3.35May 18, 26$3.28May 20, 26$3.47May 22, 26$3.46May 28, 26$3.67Jun 1, 26$3.64Jun 3, 26$3.42Jun 5, 26$3.38Jun 9, 26$3.38Jun 11, 26$3.08Jun 15, 26$2.95Jun 17, 26$2.92Jun 22, 26$2.87Jun 24, 26$2.83Jun 26, 26$2.83Jul 2, 26$2.84
$2.7652-week range$6.23
Loading valuation history…

Fundamentals

Key fundamentals

$203.3M

Market cap

27.0%

Revenue growth (YoY)

54.6%

Gross margin

-$2M

Free cash flow (USD)

-$80.8M

Net debt

Net cash position

7.1%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.4MFY 2017$18.1MFY 2018$55.2MFY 2019$245.5MFY 2020$268.7MFY 2021$245.3MFY 2022$221.3MFY 2023$223.8MFY 2024$270.3MFY 2025$343.3M
$1.4M$343.3M

Free cash flow by year

2016 → 2025

FY 2016$-8.7MFY 2017$-39.1MFY 2018$-218.6MFY 2019$-606.4MFY 2020$-691.0MFY 2021$-263.7MFY 2022$-142.5MFY 2023$-128.0MFY 2024$-85.3MFY 2025$-2.9M
-$8.7M-$2.9M

Gross margin by year

2021 → 2025

FY 2021-8.8%FY 20229.6%FY 20236.6%FY 202448.6%FY 202554.6%
-8.8%54.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 11, 2026 (EPS $0.07)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Annual reportAnnual Report FiledJun 11, 2026Filing
  • Annual report40-F FiledJun 11, 2026Filing
  • 6-K filingInvestor Conference CallMay 28, 2026Filing
  • 6-K filingAnnual General Meeting NoticeMay 21, 2026Filing
  • 6-K filingPlant Breeders' Rights GrantedMay 14, 2026Filing
  • 6-K filingProduct LaunchesApr 28, 2026Filing
  • 6-K filingAcquisition AnnouncedApr 16, 2026Filing
  • 6-K filingAcquisition AnnouncedApr 15, 2026Filing

Questions

Frequently asked questions

What is Aurora Cannabis Inc.'s market cap?

Aurora Cannabis Inc. (ACB) has a market capitalization of $203.3M.

What is ACB's P/E ratio?

A meaningful P/E ratio is not available for ACB — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did Aurora Cannabis Inc. last report earnings?

ACB last reported earnings on June 11, 2026; the next date is not yet scheduled.

Are insiders buying ACB stock?

SEC Form 4 filings show no open-market insider buys at Aurora Cannabis Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

EMBC

Embecta Corp.

$192.5M

LFCR

Lifecore Biomedical, Inc.

$187.5M

DERM

Journey Medical Corporation

$171.5M

OGI

Organigram Global Inc.

$163.3M

ASRT

Assertio Holdings, Inc.

$151.4M

TKNO

Alpha Teknova, Inc.

$270.2M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.